SCIENMAG: Medicine & Health

JULY 12, 2023

A study examining unemployment and underemployment figures and suicide rates in Australia has found both were significant drivers of suicide mortality between 2004-2016.

Research 71

Research 71

NIOSH Science Blog: Drugs

FEBRUARY 1, 2024

The National Institute for Occupational Safety and Health (NIOSH) Nanotechnology Research Center (NTRC) has taken on a global leadership role on research and guidance for nanomaterials in the workplace since the formation of NTRC in 2004 [1].

International 56

International Research 56

FDA Law Blog: Biosimilars

JUNE 13, 2024

Citing to a 2004 Supreme Court case, Verizon Commc’ns., 398 (2004), Teva argued that Amneal has no cause of action under antitrust law because the Hatch-Waxman Amendments impose a new statutory duty on a company to cooperate with competitors and established a remedy for breach of that obligation. of Trinko, LLP , 540 U.S.

FDA 113

FDA FDA Approval Production Drugs 113

Common Sense for Drug Policy Blog

FEBRUARY 22, 2024

"Leshner and others argued that broad societal acceptance of the BDMA would deliver more effective addiction treatments that health insurers would fund and make more accessible to persons with addictions ( Volkow and Li, 2004 , Dackis and O’Brien, 2005 , Leshner, 1997 ).

Disease 52

Disease Treatment Drugs 52

Common Sense for Drug Policy Blog

OCTOBER 22, 2024

The number of injection-related admissions increased 33% per year from 1997 and 1998 through 2003 and 2004. 8 According to the Hospital Episode Statistics for England 1997–2016, about 6% (n = 63,671) of SSTIs and vascular infections are injection related. 9 The most common causes were cutaneous abscess, phlebitis, and cellulitis.

Hospitals 52

Hospitals Drugs 52

FDA Law Blog: Biosimilars

SEPTEMBER 23, 2024

FDA responded to the Citizen Petitions on February 27, 2004, and issued a Press Release on March 2, 2004 (yeah, we saved that as well) concerning the PIV List. On October 4, 2000, a second Citizen Petition (FDA Legacy Docket No. 2000P-1556) was submitted by Hyman, Phelps & McNamara, P.C.,

FDA 57

FDA Drugs International Pharmaceuticals 57

Common Sense for Drug Policy Blog

NOVEMBER 15, 2024

Pseudo/ephedrine detections peaked in 2004 (17 %) but practically disappeared after 2006, when the federal ban on over-the-counter pseudoephedrine sales took effect ( Rigdon, 2012 ). Across all years, caffeine (18 %) and methamphetamine (9 %) were the most prevalent stimulant-class adulterants.

Marketing 52

Marketing Pharmaceuticals Drugs 52

Broad Institute

AUGUST 27, 2024

where she served as a director, president, and CEO prior to the acquisition of ZYCOS by MGI PHARMA in 2004. At MGI, Hedley was EVP & CSO, responsible for R&D. Prior to her role at MGI, she was a co-founder of ZYCOS Inc., Hedley is an immunologist by training and graduated with a B.S.

Science 52

Science Regulations Production Drug Development 52

Eye on FDA

AUGUST 2, 2022

The 4 letters issued this calendar year: Involved 3 Untitled Letters and 1 Warning Letter – a profile not out of proportion given that about 33 percent of letters issued since 2004 have been Warning Letters. One of the letters came to attention of FDA reviewers through the Bad Ad Program.

Pharmaceutical Companies 88

Pharmaceutical Companies FDA Pharmaceuticals Drugs 88

Broad Institute

APRIL 26, 2024

Celebrating Broad’s 20th Anniversary By Maria Nemchuk April 26, 2024 Celebrating Broad’s 20th Anniversary In 2004, the Broad Institute was founded with an ambitious goal: to leverage the newly sequenced human genome and fulfill the promise of genomic medicine.

International 52

International Research Disease 52

Drug Target Review

OCTOBER 5, 2023

The first instance of aHSCT in this cohort dates to 2004, and the average age of these patients at the time of treatment was 31, with a majority of them being women, accounting for 64 percent of the group.

Therapies 116

Therapies Treatment Clinical Trials Disease 116

NIH Director's Blog: Drug Development

OCTOBER 11, 2022

2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes. 2004, 126 (46), 15046–15047 [5] In vivo imaging of membrane associated glycans in developing zebrafish. 2004 Jul;11(7):1009-1016. Kolb, HC, Finn, MG, Sharpless, KB.

Research 52

Research Small Molecule Science Clinical Research 52

PPD

FEBRUARY 19, 2024

The European Union Clinical Trial Regulation (EU CTR) brings the biggest change in the regulatory landscape since the implementation of the EU Clinical Trials Directive in 2004, requiring vast changes in the way organizations are structured and conduct their day-to-day activities.

Clinical Trials 96

Clinical Trials Regulations Trials Clinical Research 96

Broad Institute

AUGUST 2, 2023

The design of STAR leverages unique characteristics of the 2004 tsunami to provide plausibly-causal estimates of the ramifications of disasters and traumatic exposures. The 2004 tsunami was a massive tragedy, with waves of over 30m impacting the coastline.

Medical Schools 52

Medical Schools Disease Science International 52

Drug Target Review

JUNE 19, 2024

Mr Culley served from 2007 to 2010 as Mast’s Chief Business Officer and Senior Vice President, from 2006 to 2007 as Mast’s Senior Vice President, Business Development, and from 2004 to 2006 as Mast’s Vice President, Business Development. From 2002 until 2004, Mr Culley was Director of Business Development and Marketing for Immusol, Inc.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

FDA Law Blog: Biosimilars

AUGUST 4, 2023

Because anabolic steroids are also abused to enhance athletic performance and increase muscle strength, Congress has enacted three laws regulating anabolic steroids: the Anabolic Steroid Control Acts of 1990 and 2004, and the Designer Anabolic Steroid Control Act of 2014 (“DASCA”).

Regulations 52

Regulations Production Drugs Clinical Trials 52

The Pharma Data

NOVEMBER 16, 2020

Siu Long Lee, from University College London, and colleagues evaluated the association between loneliness and depressive symptoms using data from adults aged 50 years and older in England participating in seven waves of the English Longitudinal Study of Aging (2004 to 2017; 4,211 participants).

Research 52

Research 52

The Pharma Data

DECEMBER 22, 2020

from the University of Mississippi in Jackson, and colleagues explored the association between goal-striving stress (GSS) and RKFD among 2,630 African Americans using data from the Jackson Heart Study (2000 to 2004 and 2009 to 2013). Loretta Cain-Shields, Ph.D., The researchers found that the incidence of RKFD in this sample was 7.34

Disease 52

Disease Research 52

The Pharma Data

NOVEMBER 6, 2020

Dr. Dryman continued her employment with the company as a manager from 2001 until 2004. Dr. Dryman’s professional experience has been recognized by Marquis Who’s Who since the 2004 version of Who’s Who in America. She was promoted to assistant director by the company in 1999.

Science 40

Science Doctors Engineering Research 40

The Pharma Data

MAY 14, 2021

Delivering Hope & Healing, Since 2004. Delivering Hope & Healing, Since 2004. He is now the director of The Integrative Medicine Center of Santa Barbara, which balances conventional medicine with alternative healing modalities to achieve optimal wellness. If you are. before using our products. If you are.

Testimonials 52

Testimonials Medical Schools Nurses Production 52

The Pharma Data

NOVEMBER 18, 2020

Between 2004 and 2020, 57 countries implemented surveys of HIV drug resistance using WHO-recommended methods (see map below), and 17 countries have plans to conduct surveys. Map of countries implementing national HIV drug resistance surveys, 2004–2020. .

Laboratories 52

Laboratories Therapies Virus Government 52

Drug Target Review

OCTOBER 17, 2024

He received the Markey Scholar Award in 1992, the Sears Scholar Award in 1993, and the Snyder Award for Cancer Research in 2015 and was elected to the rank of Fellow at the American Association for the Advancement of Science (AAAS) in 2004 for his pioneering contribution to innate immunity, T cell costimulation, and cancer immunology.

Immune Response 52

Immune Response Clinical Trials Trials Therapies 52

The Pharma Data

SEPTEMBER 18, 2020

In September 2004, the FDA warned the company to stop using this data to make the claims about the drug’s fewer addictive qualities. . However, the DAWN data did not prove the drug was more or less addictive but simply showed that it was abused less in certain regions.

Marketing 52

Marketing FDA Engineering Drugs 52

Pharmaceutical Development Group

AUGUST 9, 2021

Biotechnology and genomics businesses were projected to perform around one-fifth of all pharmaceutical research and development in 2004. (R&D). Many pharmaceutical goods would not have been possible without the use of biotechnologies over time.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies FDA Approval Production 52

The Pharma Data

MARCH 4, 2021

In 2004, she was appointed Global Chief Procurement Officer for all global purchases at L’Oréal, and in 2012, General Manager for Travel Retail department.

Medical Schools 52

Medical Schools Hospitals International Engineering 52

The Pharma Data

SEPTEMBER 30, 2020

The claims about Mr McMinn surfaced in a leaked report by BMI Healthcare, which ran the hospital until June this year when Circle Health Group took it over, The Independent reported.

Hospitals 52

Hospitals Licensing Licensing Regulations 52

Drug Target Review

NOVEMBER 17, 2023

Alan founded the Monash Immunology and Stem Cell Laboratories at Monash University (2004-7). He was a pioneer of human in vitro fertilisation (IVF) (1977-1996) and led the Australian team for the discovery of human embryonic stem cells in the late 1990’s and was awarded the first Australian Biotechnology of Excellence in 2003.

Therapies 118

Therapies Cell Biology Clinical Trials Trials 118

Drug Target Review

FEBRUARY 5, 2024

22 June 2004 [2024 January 26]. An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice (Acomys). 2023 April 26 [2024 January 26]; 9(17). Available from: [link] 2 Hume DA, Sasmono RT. The Innate Immune Response to Infection [Internet]. Chapter 4: The Biology of Macrophages. Wiley Online Library.

Laboratories 59

Laboratories Immune Response RNA Regulations 59

Drug Target Review

DECEMBER 28, 2023

Sergio holds a PhD from Dartmouth Medical School and from 2004 to 2010 he held a post-doctoral position at Memorial Sloan-Kettering Cancer Center. In 2016 he co-led ground-breaking research supporting the key role of clonal tumour neoantigens in the immune response to cancer; research that underpins the Achilles approach.

Bioinformatics 105

Bioinformatics Immune Response DNA Vaccine 105

Broad Institute

SEPTEMBER 5, 2024

Carr : Analyzing protein modifications has been a long term interest of mine, and it is an area that the group has focused on since we formed back in 2004.

Disease 80

Disease Protein Expression Engineering Treatment 80

FDA Law Blog: Biosimilars

MAY 23, 2023

Since then, the science and legal and regulatory framework for food allergens have evolved considerably: Congress enacted the Food Allergen Labeling and Consumer Protection Act (2004) and the Food Safety Modernization Act (2011), and FDA implemented the regulatory requirements set forth in 21 C.F.R.

FDA 44

FDA Compliance Regulations Production 44

The Pharma Data

DECEMBER 10, 2020

1, 2004 and Dec. Though this was an observational study and researchers couldn’t determine cause, it is possible that dogs with diabetes could be a kind of “sentinel,” warning owners that they, too, might be at high risk for the disease, Kennedy’s group said. 1, 2007 and Dec. 31, 2012.

Hospitals 52

Hospitals Disease Research Drugs 52

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Our projection of medical cost savings of $229,800 is substantially lower than the previous estimate of $303,100 in 2004 US dollars ($361,400 in 2012 US dollars) [ 7 ] for several reasons. First, we now account for medical costs that would have been incurred in the absence of an HIV infection.

Treatment 40

Treatment Drugs 40

The Pharma Data

APRIL 18, 2022

In August 2004, the Food Allergen Labeling and Consumer Protection Act (FALCPA) was signed into law. The draft guidance also provides the FDA’s recommendations for identifying and evaluating the relevant body of evidence to determine the public health importance of a non-listed food allergen.

FDA 52

FDA Production Vaccine Regulations 52

Alta Sciences

MAY 15, 2023

TOP 5 WAYS INTEGRATED DRUG DEVELOPMENT SOLUTIONS SAVE YOU TIME AND MONEY aasimakopoulos Mon, 05/15/2023 - 16:06 Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion , without, for the most part, shorter development timelines.

Drug Development 52

Drug Development Clinical Trials Compounding Pharmacies Laboratories 52

The Pharma Data

SEPTEMBER 15, 2020

She continued her career as a health economist and in 2004, Seredina joined S-Clinica. The results of her research were published in a number of articles highlighting her knowledge of the critical challenges of clinical sites and of the importance of being patient-centric.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Drug Target Review

SEPTEMBER 21, 2023

2004) ‘An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana’, Annals of Tropical Medicine & Parasitology, 98(3), pp. doi: 10.1002/14651858.CD011146.pub2. Awadzi, K et al. doi: 10.1179/000349804225003253.

Drugs 105

Drugs Treatment Disease Research 105